Collaborative Arrangements (Tables)

3 Months Ended

Mar. 31, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Recognized Collaborative Revenue

During the three months ended March 31, 2016 and 2015, the Company recognized the following revenues attributable to the Janssen NV collaboration:

	Three Months Ended March 31,
	2016		2015
	(in thousands)
Royalty revenues (INCIVO)	$	78	$	1,525
Collaborative revenues (telaprevir)	—		642
Total revenues attributable to the Janssen NV collaboration	$	78	$	2,167

Fair Value Of Consideration Transferred

The consideration paid and the fair value of the contingent milestone and royalty payments payable by the Company pursuant to the Parion Agreement are set forth in the table below:

	June 4, 2015
	(in thousands)
Up-front payment	$	80,000
Fair value of contingent milestone and royalty payments	175,340
Total	$	255,340

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

The following table summarizes the fair values of the assets and liabilities recorded on the effective date of the Parion Agreement:

	June 4, 2015
	(in thousands)
Intangible assets	$	255,340
Goodwill	10,468
Deferred tax liability	(91,023		)
Net other assets (liabilities)	(10,468		)
Net assets attributable to noncontrolling interests	$	164,317

Schedule of Collaborative Arrangement Activity Net Loss Attributable to Noncontrolling Interest

n aggregate summary of net loss attributable to noncontrolling interest related to the Company's VIEs for the three months ended March 31, 2016 and 2015 is as follows:

	Three Months Ended March 31,
	2016			2015
	(in thousands)
Loss attributable to noncontrolling interest before provision for income taxes	$	839		$	287
Provision for (benefit from) income taxes	3,062			(64		)
Increase in fair value of contingent milestone and royalty payments	(9,430		)	(125		)
Net (income) loss attributable to noncontrolling interest	$	(5,529	)	$	98

Schedule Of Collaborative Arrangement Summary Of Items Related To Variable Interest Entities

The following table summarizes items related to the Company's VIEs included in the Company's condensed consolidated balance sheets as of the dates set forth in the table:

	March 31, 2016		December 31, 2015
	(in thousands)
Restricted cash and cash equivalents (VIE)	$	76,273	$	78,910
Prepaid expenses and other current assets	2,818		3,138
Intangible assets	284,340		284,340
Goodwill	19,391		19,391
Other assets	434		455
Accounts payable	1,569		676
Taxes payable	24,512		24,554
Other current liabilities	6,595		7,100
Deferred tax liability, net	112,259		110,438
Other liabilities	310		300
Noncontrolling interest	159,119		153,661